Report Overview

The Global Parkinsons disease drugs market size stood at USD 2.95 billion 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Parkinsons is a neurodegenerative disease which primarily affects the human brain parts, making it difficult for the person to function or perform daily routine. People suffering from Parkinsons cannot produce enough dopamine, which leads to stiffness, tremors, walking problems, among others. This disease can become severe if not treated on time. This severity can result in increasing demand for Parkinsons disease treatment

As per Parkinsons Disease Foundation, around 10 million people across the world are suffering from Parkinsons disorder. According to Medical News Today, aggression can be toxic to Parkinsons patients. Consequently, researchers at Purdue University have found that a protein called HYPE can reduce this aggression and help patients to fight this disease



Market Drivers and Restraints

Global Parkinsons disease Treatment Market is mainly driven by growing prevalence of Parkinsons disease and government funding for research on Parkinsons disease. The increase in number of geriatric population and technological advancements such as combination therapies for prolong action of continuous dopaminergic stimulation drugs, gene therapy, neural transplantation are few other causes which are possible to boost the Parkinsons disease Treatment market. However, some restraints like availability of alternative treatments are expected to hold back market and expiry of patents for several drugs such as Stalevo, Azilect, Rytary, Comtan etc. can cause the termination of Parkinsons disease Treatment market. High cost of treatment such as 14.4 Billion USD and lack of expertise for early diagnosis is likely to restrict the market growthAlso lack of novel and successful therapies in the market to reduce the risk of mortality restraints for this market. The opportunities for Global Parkinsons disease Treatment market includes upcoming technologies like surface EMG (Electromyography) sensors, Pulse oximetry sensors, development in personalized medicine along with huge investment in anti-Parkinsons drugs research will boost the global Parkinsons disease Treatment market. Also, development of novel drugs and combination therapy with less side effects and better survival rates is expected to increase the global Parkinsons disease Treatment market